AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Glimprix-M1 Tablet

Prescription Icon
Prescription Required

Marketer

Aura Lifecare Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimprix-M1 Tablet

Diabex Duo tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by effectively managing blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose, risking kidney complications, vision loss, neuropathy, and limb amputation. Remember, Diabex Duo is only one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors. To mitigate this risk, maintain regular mealtimes and carry a readily available fast-acting glucose source, such as candy or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a possibility. Diabex Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended by your doctor.

Primary Ingredients of Glimprix-M1 Tablet

No text provided to rephrase.

Uses of Glimprix-M1 Tablet

Managing type 2 diabetes

Major Benefits of Glimprix-M1 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glimprix-M1 Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Glimprix-M1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimprix-M1 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimprix-M1 Tablet with a meal.

How Glimprix-M1 Tablet works:

Glimprix-M1 tablets contain a dual-action antidiabetic formula: Glimepiride and Metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimprix-M1 Tablet with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimprix-M1 Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Use of Glimprix-M1 tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Caution is advised when prescribing Glimprix-M1 tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician before use. Glimprix-M1 tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimprix-M1 Tablets to individuals with hepatic impairment; dosage modifications may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver disease, initiate Glimprix-M1 Tablet therapy at a reduced dosage; the medication is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glimprix-M1 Tablet :

Should you forget a Glimprix-M1 Tablet dose, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimprix-M1 Tablet

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Glimprix-M1 Tablet

Maintain this medication within its original, securely sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential side effect of Glimprix-M1 Tablet. Also known as Metformin-associated lactic acidosis (MALA), this rare but dangerous complication is particularly risky for individuals with impaired kidney function, the elderly, and those who consume significant amounts of alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or a slow pulse. Should any of these symptoms appear, discontinue Glimprix-M1 Tablet use and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimprix-M1 Tablet, treat type 2 diabetes mellitus (DM) in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Glimepiride's action involves stimulating insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin responsiveness. This dual-drug formulation is unsuitable for type 1 DM.
Glimprix-M1 Tablet administration may cause common adverse reactions including hypoglycemia, taste disturbances, nausea, abdominal discomfort, diarrhea, and cephalalgia. Rare but potentially severe side effects such as lactic acidosis may also occur. Prolonged therapy may result in vitamin B12 deficiency.
Prolonged Glimprix-M1 Tablet use can indeed lead to Vitamin B12 deficiency by hindering its absorption within the gastrointestinal tract. This deficiency, if left unaddressed, may manifest as anemia, neurological complications including peripheral neuropathy (tingling, numbness in extremities), muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive measures suggested by some studies involve supplemental Vitamin B12 at least annually.
Indeed, Glimprix-M1 Tablet administration may induce hypoglycemia, characterized by abnormally low blood glucose. Manifestations of this condition can encompass nausea, headache, irritability, increased hunger, diaphoresis, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, excessive physical exertion, or concomitant use of other antidiabetic agents. Consequently, consistent blood glucose monitoring is crucial. It is advisable to always carry a readily available source of rapid-acting carbohydrates, such as glucose tablets, honey, or fruit juice.
Consuming alcohol while taking Glimprix-M1 Tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimprix-M1 Tablet
74
MRP 90
17% off